NARAYANA HRUDAYALAYA
|
NARAYANA HRUDAYALAYA Last 5 Year Financial Ratios History
[Consolidated]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 38.64 | 29.68 | 16.74 | -0.70 | 5.82 |
| CEPS(Rs) | 50.49 | 39.96 | 25.72 | 8.28 | 14.92 |
| DPS(Rs) | 4.00 | 2.50 | 1.00 | - | 1.00 |
| Book NAV/Share(Rs) | 141.10 | 104.26 | 72.69 | 54.64 | 55.42 |
| Tax Rate(%) | 11.13 | 19.29 | 20.40 | 74.51 | 26.19 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 23.26 | 21.67 | 17.92 | 7.32 | 13.65 |
| EBIT Margin(%) | 19.93 | 18.47 | 13.67 | 1.02 | 8.16 |
| Pre Tax Margin(%) | 17.71 | 16.61 | 11.61 | -2.17 | 5.16 |
| PAT Margin (%) | 15.74 | 13.41 | 9.24 | -0.55 | 3.81 |
| Cash Profit Margin (%) | 20.56 | 18.05 | 14.20 | 6.55 | 9.75 |
| Performance Ratios | |||||
| ROA(%) | 16.15 | 16.64 | 11.59 | -0.51 | 4.31 |
| ROE(%) | 31.50 | 33.55 | 26.30 | -1.27 | 10.77 |
| ROCE(%) | 27.71 | 33.92 | 26.83 | 1.46 | 13.61 |
| Asset Turnover(x) | 1.03 | 1.24 | 1.25 | 0.91 | 1.13 |
| Sales/Fixed Asset(x) | 1.29 | 1.33 | 1.21 | 0.87 | 1.15 |
| Working Capital/Sales(x) | 6.00 | 14.75 | 28.75 | -67.78 | -201.77 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.78 | 0.75 | 0.83 | 1.15 | 0.87 |
| Receivable days | 31.03 | 35.02 | 35.27 | 38.21 | 30.85 |
| Inventory Days | 6.60 | 5.28 | 5.29 | 7.64 | 8.37 |
| Payable days | 207.08 | 193.96 | 172.49 | 207.83 | 170.21 |
| Valuation Parameters | |||||
| PER(x) | 33.13 | 26.08 | 44.59 | - | 42.53 |
| PCE(x) | 25.36 | 19.37 | 29.03 | 49.04 | 16.59 |
| Price/Book(x) | 9.07 | 7.42 | 10.27 | 7.43 | 4.46 |
| Yield(%) | 0.31 | 0.32 | 0.13 | - | 0.40 |
| EV/Net Sales(x) | 5.42 | 3.58 | 4.22 | 3.40 | 1.81 |
| EV/Core EBITDA(x) | 21.88 | 15.49 | 22.40 | 40.55 | 12.43 |
| EV/EBIT(x) | 27.18 | 19.39 | 30.90 | 334.27 | 22.18 |
| EV/CE(x) | 6.28 | 5.60 | 4.99 | 3.17 | 1.96 |
| M Cap / Sales | 5.21 | 3.50 | 4.12 | 3.21 | 1.62 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 10.91 | 22.25 | 43.29 | -17.42 | 9.33 |
| Core EBITDA Growth(%) | 18.80 | 49.87 | 222.13 | -52.41 | 45.03 |
| EBIT Growth(%) | 19.71 | 65.19 | 1,427.48 | -89.84 | 46.47 |
| PAT Growth(%) | 30.18 | 77.30 | 4,687.90 | -111.67 | 100.84 |
| EPS Growth(%) | 30.18 | 77.30 | 2,491.91 | -112.03 | 100.98 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.50 | 0.36 | 0.37 | 0.55 | 0.63 |
| Current Ratio(x) | 1.75 | 1.31 | 1.16 | 0.95 | 0.97 |
| Quick Ratio(x) | 1.65 | 1.24 | 1.09 | 0.88 | 0.87 |
| Interest Cover(x) | 8.94 | 9.94 | 6.65 | 0.32 | 2.72 |
| Total Debt/Mcap(x) | 0.06 | 0.05 | 0.04 | 0.07 | 0.14 |
Compare Financial Ratios of peers of NARAYANA HRUDAYALAYA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NARAYANA HRUDAYALAYA | ₹36,534.5 Cr | -2% | 7.3% | 43% | Stock Analytics | |
| MAX HEALTHCARE INSTITUTE | ₹103,825.0 Cr | -0.4% | -8.8% | 46% | Stock Analytics | |
| APOLLO HOSPITALS ENTERPRISE | ₹99,956.9 Cr | -2.7% | 5% | 14.9% | Stock Analytics | |
| FORTIS HEALTHCARE | ₹49,389.4 Cr | -0.4% | 4.2% | 51.4% | Stock Analytics | |
| GLOBAL HEALTH | ₹32,626.7 Cr | -3.1% | -3.9% | -12.6% | Stock Analytics | |
| KRISHNA INSTITUTE OF MEDICAL SCIENCES | ₹26,971.4 Cr | 2% | 9.8% | 69.9% | Stock Analytics | |
NARAYANA HRUDAYALAYA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NARAYANA HRUDAYALAYA | -2% |
7.3% |
43% |
| SENSEX | 0.8% |
3.8% |
8.4% |
You may also like the below Video Courses
